Clinical trial · Observational
The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
A Multi-centre Prospective Pilot Observational Cohort Study to Assess Quality of Life and Survival After Surgery for Advanced Ovarian Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary aims of the SOCQER-2 study are to describe any impact on short (6 weeks), medium term (6, 12 months) and long term (18 months, 24 months) PRO/quality of life using validated questionnaires in patients undergoing standard or extensive surgery for suspected or confirmed Stage III/IV ovarian cancer and to describe progression free survival (PFS) in these patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Neoplasms | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational cohort | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational cohort
- description
- Observational study - all suspected or confirmed ovarian cancer patients
- interventionNames
- Other: Observational cohort
Primary outcomes (1)
- measure
- Quality of life
- timeFrame
- up to 2 years
Secondary outcomes (1)
- measure
- Progression free survival
- timeFrame
- up to 2 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with suspected or confirmed ovarian cancer with macroscopic spread beyond the pelvis (FIGO stage III-IV), determined through pre-operative clinical assessment or imaging * Patient listed for primary debulking surgery or neo-adjuvant chemotherapy with the intent of interval debulking surgery Exclusion Criteria: * Ovarian cancer relapse * Progression of cancer * Informed consent not obtained. * Primary chemotherapy with no intent of interval surgery * Actively receiving treatment for another cancer * Secondary cancers \<5years or relapsed secondary cancer in the past
References
Publications (0)
Data not yet available